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Increasing incidence of small intestinal ulcers associated with nonsteroidal anti-inﬂammatory drugs (NSAIDs) has become a topic
with recent advances of endoscopic technology. However, the pathogenesis and therapy are not fully understood. The aim of this
study is to examine the eﬀect of Rikkunshito (TJ-43), a traditional herbal medicine, on expression of HSP60 and cytoprotective
ability in small intestinal cell line (IEC-6). Eﬀect of TJ-43 on HSP60 expression in IEC-6 cells was evaluated by immunoblot
analysis. The eﬀect of TJ-43 on cytoprotective abilities of IEC-6 cells against hydrogen peroxide or indomethacin was studied
by MTT assay, LDH-release assay, caspase-8 activity, and TUNEL. HSP60 was signiﬁcantly induced by TJ-43. Cell necrosis and
apoptosisweresigniﬁcantlysuppressedinIEC-6cellspretreatedbyTJ-43withoverexpressionofHSP60.Ourresultssuggestedthat
HSP60 induced by TJ-43 might play an important role in protecting small intestinal epithelial cells from apoptosis and necrosis in
vitro.
1.Introduction
Recently, it has been recognized that small intestinal ulcers
and bleeding are not rare complications of nonsteroidal
anti-inﬂammatorydrugs(NSAIDs),sincecapsuleendoscopy
and balloon enteroscopy are available for the detection of
small intestinal lesions. Graham et al. have reported that
71% of rheumatoid arthritis patients receiving NSAIDs for
at least 3 months had small intestinal mucosal lesion [1].
Sugimori et al. also have reported that more than 50% of
patients taking NSAIDs have some mucosal damage in the
small intestine [2]. Sometimes, intestinal bleeding could be a
lethalcomplication[3].PopulationwhowilltakeNSAIDsfor
cerebrovascular diseases and ischemic heart diseases is easily
predicted to increase in aging society in future. Therefore,
development of their treatment and prevention are seriously
required in clinical ﬁeld. However, much about neither the
pathogenesis nor therapy is well understood compared with
that in the gastric mucosal lesions associated with NSAIDs.
Many studies have shown the importance of heat shock
proteins (HSPs, molecular chaperones) for survival of cells
under stress conditions [4, 5]. It has been focused on the
cytoprotective functions of HSPs, which include folding or
assembly of degenerated proteins to normalize intracellular
environment, under stressed conditions mediated by chap-
eron function of HSPs. These functions are considered to
be essential for living cells to obtain tolerance to adapt to
environmental changes [6, 7]. Cytoprotective functions of
a 70-kDa-heat shock protein (HSP70) and a 60-kDa-heat
shock protein (HSP60) have been demonstrated in several
experimental models including the stomach and colon [8–
13]. In the gastric mucosa, some antiulcer drugs such as
geranylgeranylacetone (GGA) or zinc L-carnosine have been
reported to induce gastric mucosal HSP70 and enhance
mucosal protective ability both in vitro and in vivo [11, 14].
These “nontoxic chaperone inducers” are considered to be
new therapeutic strategy for gastric mucosal injury. We pre-
viously have reported that when HSP60 was overexpressed2 Evidence-Based Complementary and Alternative Medicine
by cDNA transfection in the intestinal epithelial cells, the
cytoprotective ability could be dramatically enhanced [15].
Rikkunshito (TJ-43) is a traditional Japanese herbal
medicine used for dyspeptic symptom and chronic gastritis.
In the present study, we aimed to evaluate whether TJ-43
could have therapeutic value for therapy of NSAID-induced
mucosal damage as a nontoxic chaperone (HSP60) inducer
in the small intestinal cells.
2.SubjectsandMethods
2.1. Rat Small Intestinal Cell Line. A rat small intestinal
epithelial cell line (IEC-6) was obtained from Riken Cell
Bank (Tsukuba, Japan). This cell line was cultured in 1640
RPMI medium (Gibco, NY, USA) with 10% fetal bovine
serum at 37◦Ci naC O 2 incubator.
2.2. Eﬀect of TJ-43 on HSP60 Expression in IEC-6 Cells. IEC-
6 cells were treated with 2.0mg/mL of TJ-43 in serum-
free medium for 2h. This condition is eﬀectively induces
HSP60 without cytotoxicity in IEC-6 cells. IEC-6 cells were
harvested 6h after TJ-43 exposure. The cells were homog-
enized with 5 volumes of ice-cold 25mM Tris-Cl buﬀer
(pH 7.5). The homogenates were centrifuged at 15,000×g
for 10min. The protein concentration was measured by
the method of Bradford [16]. Samples were analyzed by
9% polyacrylamide gel electrophoresis according to the
method of Laemmli [17]. Brieﬂy, samples (20µg/lane) were
electrophoresed on 9% SDS-polyacrylamide gels, transferred
electrophoretically to PVDF membrane (removal rating,
0.45µm; Amersham Pharmacia Biotech, Buckinghamshire,
England), and processed as described by Towbin et al.
[18]. The membrane was incubated with anti-HSP60 anti-
body (StressGen, Victoria BC, Canada) and treated with
horseradish peroxidase conjugated antirabbit IgG (1:1500)
(Bio-Rad, Richmond, Calif., USA). As an internal control,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
detected by anti-GAPDH antibody (Santa Cruz, Calif.,
USA). The stained bands were visualized with 0.02% 3,
3-diaminobenzidine tetrahydrochloride containing 0.005%
hydrogen peroxide. The density of the immunologically
stained band was analyzed by scanning densitometer using
Multi-Gauge (ver 3.0) (Fujiﬁlm, Tokyo, Japan) program
according to the method we previously reported [13]. The
relative density of HSP60 was calculated using next formula:
relative density (%) = density ratio (HSP60/GAPDH, after
TJ-43 treatment)/density ratio (HSP60/GAPDH, before TJ-
43 treatment)×100.
2.3. Eﬀect of TJ-43 on Antinecrotic Ability of IEC-6 Cells.
IEC-6 cells were seeded into 96-well ﬂat-bottom culture
plates at a density of 3×104/mL and incubated for 24h
after exchanging the medium to serum-free medium. Cyto-
protective ability of IEC-6 cells against hydrogen peroxide-
(0–0.18mM) or indomethacin- (0–2.4mM) induced cell
damage was analyzed with or without pretreatment with
2.0mg/mL of TJ-43 for 2h [12, 15] .T h ec e l lv i a b i l i t y
was measured by modiﬁed MTT (3-(4,5-di-methylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide, yellow tetrazole)
assay (CellTiter 96 Nonradioactive Cell Proliferation Assay,
Promega, Wis, USA) 6h after exposure of the cells to
hydrogen peroxide or indomethacin. The cell survival
(%) was evaluated using next formula. Relative cell sur-
vival (%) = [absorbance (in each hydrogen peroxide
or indomethacin concentration)/absorbance (at 0mM of
hydrogen peroxide or indomethacin)] ×100. Cytoprotec-
tive ability of IEC-6 cells against hydrogen peroxide- (0–
0.4mM) or indomethacin- (0–4.0mM) induced direct plas-
mamembrane damage was analyzed by lactate dehydroge-
nase (LDH)-release assay using a CytoTox 96 Nonradioactive
Cytotoxicity Assay (Promega, Wis, USA), with or without
pretreatment with TJ-43. The relative (%) cell necrosis was
evaluated using the next formula. Relative cell necrosis (%)
= [absorbance (in each hydrogen peroxide or indomethacin
concentration)/absorbance(maximumLDH-release)] ×100.
2.4. Eﬀect of TJ-43 on Antiapoptotic Ability of IEC-6 Cells.
Antiapoptotic abilities of IEC-6 cells and IEC-6 cells treated
with TJ-43 were compared based on MTT assay, TUNEL
staining, and caspase-8 activity after exposure of these cells
to low concentration of hydrogen peroxide (0–0.16mM) or
indomethacin (0–1.0mM) for 18h in serum-free medium
[12, 15] .T h er e l a t i v ec e l ls u r v i v a l( % )w a se v a l u a t e db y
MTT assay and the next formula. Relative cell survival (%)
= [absorbance (in each hydrogen peroxide or indomethacin
concentration)/absorbance (at 0mM of hydrogen peroxide
or indomethacin)]×100. Apoptotic cells were ﬂuorescence
microscopically detected by TUNEL (tdT-mediated dUTP
nick-end labeling) staining (DeadEnd Fluorometric TUNEL
System, Promega, Wis, USA) in green color ﬂuorescence in a
blue background of all cells. The ratio of apoptotic cells was
counted by two observers who were blind to the group.
The caspase-8 activity in the cells was measured using
Caspase-Glo 8 Assay kit (Promega, Wis, USA) after expo-
sure of IEC-6 cells to hydrogen peroxide (0–0.1mM) or
indomethacin (0–0.6mM) with or without pretreatment
with TJ-43.
2.5. Data Analysis. A l ld a t aw e r ee x p r e s s e da sm e a n s±
SEM with at least three separate experiments using more
than six samples in each experiments (n> 18). Statistical
analysis was performed using Student’s t-test, where it was
appropriate, after ANOVA analysis; P<0.05 was considered
to be statistically signiﬁcant.
3. Results
3.1. Expression of HSP60 after TJ-43 Treatment. As shown
in Figure 1, TJ-43 signiﬁcantly induced HSP60 expression
(approximately 2-fold) compared with that in IEC-6 cells
determined by immunoblotting with quantiﬁcation by
densitometric data normalized by internal control protein
(GAPDH) (P<0.01).Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Western blot analysis. TJ-43 signiﬁcantly induced the expression levels of HSP60 in IEC-6 cells ∗∗P<0.01 compared with control
cells.
3.2. Eﬀect of TJ-43 on Cytoprotective Ability of IEC-6 Cells
3.2.1.AntinecroticAbility. AsshowninFigure 2(a),h ydr ogen
peroxide-induced cell necrosis was signiﬁcantly suppressed
in IEC-6 cells pretreated with TJ-43 compared with non-
treated IEC-6 cells under necrotic condition based on MTT
assay. IEC-6 cells treated with TJ-43 also showed greater via-
bility against indomethacin-induced cell necrosis compared
with nontreated IEC-6 cells (Figure 2(c)). The direct plasma
membranedamage(necrosis)basedonLDH-releasewasalso
signiﬁcantly reduced in TJ-43 pretreated IEC-6 cells com-
pared with nontreated IEC-6 cells (Figures 2(b) and 2(d)).
3.2.2. Antiapoptotic Ability. As shown in Figures 3(a) and
3(c), hydrogen peroxide- or indomethacin-induced apopto-
sis was signiﬁcantly suppressed in IEC-6 cells pretreated with
TJ-43comparedwithnontreatedIEC-6cellsbasedonthecell
survival. Activity of the caspase-8 was signiﬁcantly reduced
in IEC-6 cells treated with TJ-43 compared with nontreated
IEC-6 cells (Figures 3(b) and 3(d)). To characterize the
cell death induced by hydrogen peroxide or indomethacin,
nuclear morphology of apoptotic cells was also examined
with a ﬂuorescent DNA-binding agent (TUNEL staining).
Cells treated with hydrogen peroxide or indomethacin
showed typical morphological features of apoptotic cells
with condensed and fragmented nuclei (Figure 4(a)). Ratio
of apoptotic cells was signiﬁcantly reduced in IEC-6 cells
treated with TJ-43 compared with untreated control cells
(Figure 4(b)).
4. Discussion
Results of our present study clearly demonstrated the
enhancement of cytoprotective ability in IEC-6 cells pre-
treated with TJ-43 to induce HSP60 (molecular chaperone)
compared with nontreated control cells. The enhanced
cytoprotective ability was observed under both necrotic
and apoptotic conditions induced by hydrogen peroxide or
indomethacin.
NSAIDs are widely used in many clinical ﬁelds such
as cardiovascular, rheumatic, and orthopedic diseases.
Recent advances in diagnostic methods, including capsule
endoscopy and double balloon enteroscopy, have enabled to
examine the entire small intestine, and it is now acknowl-
edged that small intestinal lesions are not rare as considered
before [1, 2, 19, 20]. Gastrointestinal bleeding is one of
the most serious well-known adverse reactions of NSAIDs.
Gastric mucosal lesion is a well-investigated complication
that is mainly caused by cyclooxygenase (COX)- 1 inhibition
resulting in decrease of prostaglandin E2 in the gastric
mucosa [21, 22]. Also, gastric acid has been reported
to be an exacerbation factor of NSAID-induced gastric
mucosal damage [23]. Therefore, prostaglandin derivatives
and proton pump inhibitors (PPI) have been considered as
evidence-based therapeutic tools for NSAID-induced gastric
mucosal injury [24, 25]. Further, as internal gastric mucosal
protectant, molecular chaperone, especially HSP70, has been
reported to be a candidate of therapeutic tool for NSAID-
induced gastric mucosal lesion [10]. In order to induce
gastric mucosal HSP70, some nontoxic chaperone inducers
have been developed such as GGA and zinc-L-carnosine
which are commercially available antiulcer drugs used for
gastritis and gastric ulcer in Japan and some Asian countries
[11, 13, 14]. As an induction mechanism of HSP, we have
reported that heat shock transcription factor 1 (HSF-1)
was activated by these drugs [26]. These antiulcer drugs
predominantly increase gastric mucosal protective ability4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Antinecrotic ability. Hydrogen peroxide-(a) or Indomethacin-(c) induced cell necrosis was signiﬁcantly suppressed in IEC-6 cells
pretreated with TJ-43 compared with nontreated IEC-6 cells under necrotic condition based on MTT assay. Cytotoxicity, based on LDH-
release after hydrogen peroxide- (b) or indomethacin- (d) treatment was also signiﬁcantly reduced in TJ-43 pretreated IEC-6 cells compared
with nontreated IEC-6 cells (control cells). Values are means ± SEM. ∗P<0.05, ∗∗P<0.01 compared with control cells.
against NSAIDs, ethanol, and hydrogen peroxide [8, 14]. On
the other hand, little has been known about the pathogenesis
and therapy of small intestinal lesions induced by NSAIDs.
It has been reported that PPI or prostaglandin E may not
have suﬃcient eﬀect for small intestinal damage [27, 28].
Although HSP70 is an important molecular chaperone in
the gastric mucosa as mentioned above, HSP60 has been
reported to mainly contribute to small intestinal mucosal
protection whereas induction of HSP70 did not enhance
the protective ability [15]. Therefore, it is considered that
medications that increase HSP60 in the small intestinal
epithelial cells could be new therapeutic tools for small
intestinal mucosal damage.
TJ-43 is a traditional Japanese herbal medicine extracted
from a mixture of Atractylodis Lanceae Rhizoma, Gin-
seng Radix, Pinelliae Tuber, Hoelen, Zizyphi Fructus,Evidence-Based Complementary and Alternative Medicine 5
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Figure3:Antiapoptoticability.Hydrogenperoxide-orindomethacin-inducedapoptosisevaluatedbyMTTassay(a,c)andcaspase-8activity
(b, d) was signiﬁcantly suppressed in TJ-43 pretreated IEC-6 cells compared with nontreated IEC-6 cells (control cells). Values are means ±
SEM. ∗P<0.05, ∗∗P< 0.01 compared with control cells.
Aurantii Nobilis Pericarpium, Glycyrrhizae Radix, and Zin-
giberis Rhizoma [29]. TJ-43 has been reported to improve
dyspeptic symptom by reversing an existing impaired adap-
tive relaxation [29–31], leading to an improvement of
delayed gastric emptying mediated by ghrelin receptor and
5-HT2 receptor antagonism [29–32]. Also, some herbal
medicines inducing TJ-43 have been reported to protect
gastric mucosal epithelial cells from oxidative injury. One of
the mechanisms for mucosal protection has been considered
to be mediated by their antioxidant activities as a radical
scavenger [33].
We previously have reported that when HSP60 is overex-
pressed by cDNA transfection technique, the cytoprotective
ability is enhanced in the small intestinal mucosal cell6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: TUNEL staining. (a); IEC-6 cells treated with hydrogen peroxide or indomethacin showed typical morphological features of
apoptotic cells with condensed and fragment nuclei. When IEC-6 cells were pretreated with TJ-43, apoptosis was apparently suppressed. (b);
Ratio of apoptotic cells signiﬁcantly reduced in IEC-6 cells treated with TJ-43 compared with control cells (untreated IEC-6 cells). Values are
means ± SEM. ∗P<0.05, ∗∗P<0.01 compared with control cells (IEC-6-mock cells).
[15]. However, in view of clinical application of chaperone-
inducing therapy, cDNA transfection may not be practical.
It could be convenient if nontoxic drugs could eﬀectively
induce HSP60 in the small intestinal mucosa. In the present
study, TJ-43 exerts protective eﬀects of the small intestinal
epithelial cells against not only oxidative injury but also
NSAID-induced cell damage with increase in the level of
HSP60. These results indicate that TJ-43 can be a “nontoxic
chaperone (HSP60) inducer” in the small intestine.
5. Conclusion
The present paper provides the ﬁrst evidence of mucosal
protective eﬀect of TJ-43 from small intestinal damage
induced by indomethacin or oxidative injury with induction
of molecular chaperone (HSP60). In the therapeutic point
of view, it is suggested here that “chaperone-inducing herbal
medicine therapy” could be an important candidate of a
new strategy for small intestinal mucosal injury including
inﬂammatory bowel diseases and NSAID-induced small
intestinal mucosal injury.
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